Bharti Airtel Strengthens Overseas Bet by Raising Stakes in Africa Venture and UKs BT Group BofA Increases Philip Morris International Price Target by 9 Cites Strong Outlook Krispy Kremes 16 Million Data Breach Settlement Deadline Approaches HighYield Savings Rates on May 23 2026 Top Accounts Offer Up to 41 APY Diamondback Energy Capitalizes on Oil Price Surge Amid Supply Disruptions Core Scientific Targets 15 GW Power Capacity at Muskogee Campus in Major Expansion Plan Emerson Radio Corporation MSN Q1 2024 Earnings Narrow Loss Reported Amid Quiet Quarter Stock Surges 20 ULTA Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains on Resilient Demand FRST Q1 2026 Earnings Strong EPS Surprise Driven by Core Income Strength PARR Q1 2026 Earnings EPS Misses Estimates Stock Declines Holley Inc Q1 2026 Earnings EPS Misses Estimates by 11 Shares Rise Despite Uncertainty Amplitech Group Inc AMPGZ Q1 2026 Earnings EPS Miss and Steep Stock Decline Highlight Ongoing Challenges Distribution Solutions Group DSGR Holds Steady as Shares Trade Near Range Midpoint Tungray Technologies TRSG Holds Steady at 116 as Traders Eye Key Support and Resistance Levels Camping World Holdings CWH Extends Decline as Recreational Vehicle Demand Remains Under Pressure Aptorum Group Limited APM Hovers Near Support at 080 After Marginal Decline Biglari Holdings BH Declines 27 as It Approaches Key Support Near 262 Singapore High Court Criticizes UOB Over Inconsistent Legal Stance on Late Mortgage Charges George Soros Fund Takes Stake in Talkspace Telehealth Growth Potential Veteran Trader Steve Burns Issues Bear Market Warning Highlights Three Investor Pitfalls Fanatics Secures FIFA Exclusive Collectibles License Expanding Dominance in Sports Memorabilia UK Police Chiefs Call for Social Media Block on Under16s Over Safety Risks Standard Chartered Plans 15 Reduction in Corporate Functions Roles Targets Higher Returns The Turnaround Leader Who Rejected Silicon Valleys GrowthAtAllCosts Playbook Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD IO Biotech Holds Steady at 005 Navigating Extremely Low Valuation Territory